SUN.L
Surgical Innovations Group PLC
Price:  
0.70 
GBP
Volume:  
2,863,627.00
United Kingdom | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUN.L WACC - Weighted Average Cost of Capital

The WACC of Surgical Innovations Group PLC (SUN.L) is 6.9%.

The Cost of Equity of Surgical Innovations Group PLC (SUN.L) is 7.50%.
The Cost of Debt of Surgical Innovations Group PLC (SUN.L) is 4.60%.

Range Selected
Cost of equity 6.30% - 8.70% 7.50%
Tax rate 15.30% - 25.30% 20.30%
Cost of debt 4.00% - 5.20% 4.60%
WACC 5.8% - 8.0% 6.9%
WACC

SUN.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.39 0.54
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.70%
Tax rate 15.30% 25.30%
Debt/Equity ratio 0.19 0.19
Cost of debt 4.00% 5.20%
After-tax WACC 5.8% 8.0%
Selected WACC 6.9%

SUN.L's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SUN.L:

cost_of_equity (7.50%) = risk_free_rate (4.25%) + equity_risk_premium (6.50%) * adjusted_beta (0.39) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.